Recombinant multi-species IFIH1 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis
Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine IFIH1 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
IFIH1 encodes MDA5 which is an intracellular sensor of viral RNA that triggers the innate immune response. Sensing RNA length and secondary structure, MDA5 binds dsRNA oligonucleotides with a modified DExD/H-box helicase core and a C-terminal domain, thus leading to a proinflammatory response that includes interferons. It has been shown that Coronaviruses (CoVs) as well as various other virus families, are capable of evading the MDA5-dependent interferon response, thus impeding the activation of the innate immune response to infection. MDA5 has also been shown to play an important role in enhancing natural killer cell function in malaria infection. In addition to its protective role in antiviral responses, MDA5 has been implicated in autoimmune and autoinflammatory diseases such as type 1 diabetes, systemic lupus erythematosus, and Aicardi-Goutieres syndrome[provided by RefSeq, Jul 2020]
The Alternative Names of target: 9130009C22Rik,AGS7,Clinically amyopathic dermatomyositis autoantigen 140 kDa (CADM-140 autoantigen),Helicard,Helicase with 2 CARD domains (Helicard),Hlcd,IDDM19,IFIH1,IMD95,Ifih1,Interferon-induced helicase C domain-containing protein 1,Interferon-induced with helicase C domain protein 1,MDA-5,MDA5,Melanoma differentiation-associated protein 5 (MDA-5),Murabutide down-regulated protein,RGD1560496,RIG-I-like receptor 2 (RLR-2),RLR-2,RNA helicase-DEAD box protein 116,SGMRT1
Go
to IFIH1 products collection
>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product information
| Catalog No. | Product Name | Species Reactivity |
|---|---|---|
| GM-Tg-hg-IP11112-Ag-1/ GM-Tg-hg-IP11112-Ag-2 | Human IFIH1 protein | Human |
| GM-Tg-rg-IP11112-Ag-1/ GM-Tg-rg-IP11112-Ag-2 | Rat IFIH1 protein | Rat |
| GM-Tg-mg-IP11112-Ag-1/ GM-Tg-mg-IP11112-Ag-2 | Mouse IFIH1 protein | Mouse |
| GM-Tg-cynog-IP11112-Ag-1/ GM-Tg-cynog-IP11112-Ag-2 | Cynomolgus/Rhesus macaque IFIH1 protein | Cynomolgus/ Rhesus macaque |
| GM-Tg-felg-IP11112-Ag-1/ GM-Tg-felg-IP11112-Ag-2 | Feline IFIH1 protein | Feline |
| GM-Tg-cang-IP11112-Ag-1/ GM-Tg-cang-IP11112-Ag-2 | Canine IFIH1 protein | Canine |
| GM-Tg-bovg-IP11112-Ag-1/ GM-Tg-bovg-IP11112-Ag-2 | Bovine IFIH1 protein | Bovine |
| GM-Tg-equg-IP11112-Ag-1/ GM-Tg-equg-IP11112-Ag-2 | Equine IFIH1 protein | Equine |
Size: 1mg | 10mg | 100mg
Product Description
| Catalog No. |
GM-Tg-hg-IP11112-Ag-1/ GM-Tg-hg-IP11112-Ag-2;
GM-Tg-rg-IP11112-Ag-1/ GM-Tg-rg-IP11112-Ag-2;
GM-Tg-mg-IP11112-Ag-1/ GM-Tg-mg-IP11112-Ag-2; GM-Tg-cynog-IP11112-Ag-1/ GM-Tg-cynog-IP11112-Ag-2; GM-Tg-felg-IP11112-Ag-1/ GM-Tg-felg-IP11112-Ag-2; GM-Tg-cang-IP11112-Ag-1/ GM-Tg-cang-IP11112-Ag-2; GM-Tg-bovg-IP11112-Ag-1/ GM-Tg-bovg-IP11112-Ag-2; GM-Tg-equg-IP11112-Ag-1/ GM-Tg-equg-IP11112-Ag-2 |
| Products Name | IFIH1 protein |
| Species | Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine |
| Target Name | IFIH1 |
| Protein Sub-location | Introcelluar Protein |
| Isotypes | Recombinant protein |
| Expression platform | Mammalian cell |
| Bioactivity validation | Affintiy&bioactivity validated by ELISA, cell culture validated. |
| Tag | His |
| Products description | Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine IFIH1 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic). |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
| Formulation & Reconstitution |
Lyophilized from GM's Protein Stability Buffer2
(PSB2,Confidential Ingredients) or PBS
(pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
About Gmab

GMab, developed by GeneMedi, constitutes an
advanced library of recombinant
monoclonal antibodies, each meticulously
designed to target specific molecular
entities. Leveraging the sophisticated
capabilities of GM’s Taurus™ and LIBRA™
platforms, GMab synthesizes antibodies
characterized by high binding affinity,
exceptional physicochemical stability, and
optimal developability profiles.
Through
expression in mammalian cell lines, GMab has
been established as a paradigmatic
reference antibody. It holds significance in
myriad domains of biological drug
discovery, encompassing cellular cultivation,
innovative assay methodologies,
strategic animal model systematization, in-depth
pharmacokinetic & pharmacodynamic
(PK/PD) modeling, and intricate mechanism of
action (MOA) investigations.